States should have the authority to study medical marijuana on their own terms, according to a new lobbying group representing pot investors and farmers.
The National Cannabis Roundtable is urging Congress to create more medical research opportunities for marijuana-based companies through individual state laws. They could do that by exempting states where pot is legal from federal enforcement.
The group hosted it’s first in-person board meeting Feb. 27 to discuss this and other goals, according to Kevin Murphy, the group’s chairman, who is also CEO of Acreage Holdings. The N.Y.-based company grows and dispenses marijuana in 11 states.
Murphy said ...
Learn more about Bloomberg Law or Log In to keep reading:
Learn About Bloomberg Law
AI-powered legal analytics, workflow tools and premium legal & business news.
Already a subscriber?
Log in to keep reading or access research tools.